Ansari, M., Porouhan, P., Mohammadianpanah, M., Omidvari, S., Mosalaei, A., Ahmadloo, N., . . . Hamedi, S. H. (2016). Efficacy of ginger in control of chemotherapy induced nausea and vomiting in breast cancer patients receiving doxorubicin-based chemotherapy. Asian Pacific Journal of Cancer Prevention, 17, 3877–3880.
To evaluate the efficacy of adding powdered ginger to prevent chemotherapy-induced nausea and vomiting (CINV) in women with breast cancer receiving moderately emetogenic chemotherapy
Women with breast cancer were randomized to receive either 500 mg ginger or placebo twice a day for three days, during the course of three cycles of chemotherapy.
PHASE OF CARE: Active antitumor treatment
Double-blind, randomized, longitudinal
Not described; only states that participants were asked to “record the episodes of vomiting and nausea severity”
No significant difference in nausea or vomiting existed when comparing the ginger group to the placebo group.
The results of this study do not indicate that powdered ginger capsules (1 g daily) are effective in reducing CINV in women with breast cancer receiving chemotherapy.
Measurement/methods not well described
Powdered ginger capsules may not offer CINV relief for patients receiving chemotherapy.